QUETIAPIN FOR THE TREATMENT OF DYSKINESIA IN NON-PSYCHOTIC PATIENTS

摘要

A method for treating dyskinesias associated with dopaminergic therapy is described using the a typical antipsychotic agent quetiapine. Also described is the co-administration of quetiapine and a dopaminergic agent for treating Parkinson's disease. Treatment with quetiapine suppresses the symptoms of Parkinson's disease and will attenuate levodopa-induced dyskinetic movements. This allows the dosage of dopaminergic agents, for example levodopa, to be increased without the complicating side-effects normally observed with higher doses.